Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 87 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma

Khare Shruti, Lila Anurag R, Patil Rishikesh, Phadke Milind, Kerkar Prafulla, Bandgar Tushar, Shah Nalini S

Year : 2017| Volume: 21| Issue : 1 | Page no: 154-159

   This article has been cited by
 
1 Serum prolactin levels across pregnancy and the establishment of reference intervals
Yun Hu,Yiling Ding,Mengyuan Yang,Zhongyuan Xiang
Clinical Chemistry and Laboratory Medicine (CCLM). 2018; 56(5): 803
[Pubmed]  [Google Scholar] [DOI]
2 The Third Case of Cabergoline-Associated Valvulopathy: The Value of Routine Cardiovascular Examination for Screening
Carmela Caputo,David Prior,Warrick J Inder
Journal of the Endocrine Society. 2018; 2(8): 965
[Pubmed]  [Google Scholar] [DOI]
3 Cabergoline
Reactions Weekly. 2017; 1642(1): 73
[Pubmed]  [Google Scholar] [DOI]

 

Read this article